HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysis. - Villacampa G; Pascual T; Tarantino P; Cortés J; Perez-García J; Llombart-Cussac A; Conte P; Mancino M; Guarneri V; Dieci MV; Waks AG; Schettini F; et al. (The Lancet. Oncology, 2025)